ArticleProstate cancer and prostatic diseases2022

Transcriptome subtyping of metastatic Castration Resistance Prostate Cancer (mCRPC) for the precision therapeutics: an in silico analysis.

Yingchun Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.